Symbols / MMSI Stock $66.74 +2.92% Merit Medical Systems, Inc.

Healthcare • Medical Instruments & Supplies • United States • NMS
MMSI (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Ms. Martha Goldberg Aronson
Exch · Country NMS · United States
Market Cap 3.98B
Enterprise Value 4.23B
Income 128.49M
Sales 1.52B
FCF (ttm) 179.71M
Book/sh 26.66
Cash/sh 7.51
Employees 7,500
Insider 10d —
IPO May 14, 1990
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 31.33
Forward P/E 15.21
PEG 1.39
P/S 2.63
P/B 2.50
P/C —
EV/EBITDA 13.34
EV/Sales 2.79
Quick Ratio 2.79
Current Ratio 4.34
Debt/Eq 51.86
LT Debt/Eq —
EPS (ttm) 2.13
EPS next Y 4.39
EPS Growth 38.80%
Revenue Growth 10.90%
EPS Gr Q/Q 36.00%
Rev Gr Q/Q —
Earnings (next) 2026-04-30
Earnings (prior) 2026-02-24
ROA 4.75%
ROE 8.67%
ROIC —
Gross Margin 48.70%
Oper. Margin 15.78%
Profit Margin 8.48%
Shs Outstand 59.65M
Shs Float 58.09M
Insider Own 2.37%
Instit Own 108.40%
Short Float 6.68%
Short Ratio 3.93
Short Interest 2.95M
52W High 100.19
vs 52W High -33.39%
52W Low 63.78
vs 52W Low 4.63%
Beta 0.65
Impl. Vol. 52.15%
Rel Volume 0.62
Avg Volume 732.78K
Volume 455.82K
Target (mean) $98.36
Tgt Median $100.00
Tgt Low $78.00
Tgt High $122.00
# Analysts 11
Recom Buy
Prev Close $64.84
Price $66.73
Change 2.92%
About

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$98.36
Mean price target
2. Current target
$66.74
Latest analyst target
3. DCF / Fair value
$54.23
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$66.74
Low
$78.00
High
$122.00
Mean
$98.36

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-20 main Barrington Research Outperform → Outperform $107
2026-04-17 main Piper Sandler Overweight → Overweight $96
2026-04-07 main Canaccord Genuity Buy → Buy $90
2026-04-01 reit Needham Buy → Buy $101
2026-02-26 down Wells Fargo Overweight → Equal-Weight $78
2026-02-25 main Barrington Research Outperform → Outperform $109
2026-02-25 main Needham Buy → Buy $101
2026-02-18 main Piper Sandler Overweight → Overweight $106
2026-02-06 init BTIG — → Buy $107
2026-01-09 reit Needham Buy → Buy $108
2025-12-17 main Canaccord Genuity Buy → Buy $99
2025-11-14 main Barrington Research Outperform → Outperform $106
2025-11-14 main Canaccord Genuity Buy → Buy $93
2025-11-14 main Wells Fargo Overweight → Overweight $95
2025-10-31 main Barrington Research Outperform → Outperform $106
2025-10-31 reit Piper Sandler Overweight → Overweight $109
2025-10-31 reit Needham Buy → Buy $108
2025-10-16 main Canaccord Genuity Buy → Buy $104
2025-10-07 main Barrington Research Outperform → Outperform $103
2025-09-23 main Barrington Research Outperform → Outperform $103
News
RSS: Latest MMSI news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-26 LLOYD BRIAN G Officer — 33,665 $0.00 $0
2026-02-26 PARRA RAUL JR. Chief Financial Officer — 38,920 $0.00 $0
2026-02-26 VOIGT MICHEL JAMES Officer — 31,101 $0.00 $0
2026-02-26 PETERSON NEIL W Chief Operating Officer — 24,692 $0.00 $0
2026-02-26 SMITH CHRISTIAN ADAM Officer — 21,374 $0.00 $0
2026-02-26 ARONSON MARTHA GOLDBERG Chief Executive Officer — 28,198 $0.00 $0
2026-01-06 PETERSON NEIL W Chief Operating Officer — 5,000 $90.00 $450,000
2026-01-06 PETERSON NEIL W Chief Operating Officer — 5,000 $54.40 $272,000
2025-11-25 LAMPROPOULOS FRED P Officer and Director — 10,000 $88.04 $880,377
2025-11-21 LAMPROPOULOS FRED P Officer and Director — 25,000 $87.31 $2,182,750
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,515.91
+11.75%
1,356.51
+7.89%
1,257.37
+9.24%
1,150.98
Operating Revenue
1,515.91
+11.75%
1,356.51
+7.89%
1,257.37
+9.24%
1,150.98
Cost Of Revenue
777.64
+9.04%
713.18
+5.89%
673.49
+6.59%
631.88
Reconciled Cost Of Revenue
777.64
+9.04%
713.18
+5.89%
673.49
+6.59%
631.88
Gross Profit
738.27
+14.76%
643.33
+10.18%
583.87
+12.48%
519.10
Operating Expense
552.57
+13.42%
487.20
+6.75%
456.40
+9.18%
418.04
Research And Development
97.35
+11.30%
87.47
+5.73%
82.73
+9.56%
75.51
Selling General And Administration
455.21
+13.88%
399.73
+6.97%
373.68
+9.09%
342.52
Total Expenses
1,330.20
+10.82%
1,200.38
+6.24%
1,129.90
+7.62%
1,049.92
Operating Income
185.70
+18.94%
156.14
+22.49%
127.47
+26.13%
101.06
Total Operating Income As Reported
184.72
+18.64%
155.69
+25.62%
123.94
+41.55%
87.56
EBITDA
332.05
+12.20%
295.94
+29.29%
228.89
+26.34%
181.17
Normalized EBITDA
333.03
+12.36%
296.39
+27.52%
232.42
+19.39%
194.67
Reconciled Depreciation
134.65
+17.36%
114.73
+13.27%
101.29
+9.86%
92.20
EBIT
197.40
+8.93%
181.21
+42.02%
127.60
+43.42%
88.97
Total Unusual Items
-0.98
-122.12%
-0.44
+87.43%
-3.52
+73.90%
-13.50
Total Unusual Items Excluding Goodwill
-0.98
-122.12%
-0.44
+87.43%
-3.52
+73.90%
-13.50
Special Income Charges
-0.98
-122.12%
-0.44
+87.43%
-3.52
+73.90%
-13.50
Other Special Charges
—
—
1.55
-76.77%
6.67
Impairment Of Capital Assets
0.00
0.00
-100.00%
0.27
-87.83%
2.22
Restructuring And Mergern Acquisition
0.98
+122.12%
0.44
-74.00%
1.70
-63.04%
4.61
Net Income
128.49
+6.76%
120.36
+27.48%
94.41
+26.70%
74.52
Pretax Income
170.94
+13.96%
149.99
+33.82%
112.09
+35.65%
82.63
Net Non Operating Interest Income Expense
-11.39
-128.32%
-4.99
+61.78%
-13.05
-121.27%
-5.90
Interest Expense Non Operating
26.46
-15.24%
31.22
+101.27%
15.51
+144.69%
6.34
Net Interest Income
-11.39
-128.32%
-4.99
+61.78%
-13.05
-121.27%
-5.90
Interest Expense
26.46
-15.24%
31.22
+101.27%
15.51
+144.69%
6.34
Interest Income Non Operating
15.07
-42.55%
26.23
+968.00%
2.46
+459.45%
0.44
Interest Income
15.07
-42.55%
26.23
+968.00%
2.46
+459.45%
0.44
Other Income Expense
-3.38
-192.55%
-1.15
+50.34%
-2.32
+81.46%
-12.54
Other Non Operating Income Expenses
-2.39
-236.43%
-0.71
-159.25%
1.20
+24.22%
0.97
Tax Provision
42.45
+43.23%
29.64
+67.64%
17.68
+117.90%
8.11
Tax Rate For Calcs
0.00
+25.25%
0.00
+25.32%
0.00
+61.22%
0.00
Tax Effect Of Unusual Items
-0.24
-178.21%
-0.09
+84.25%
-0.56
+57.92%
-1.32
Net Income Including Noncontrolling Interests
128.49
+6.76%
120.36
+27.48%
94.41
+26.70%
74.52
Net Income From Continuing Operation Net Minority Interest
128.49
+6.76%
120.36
+27.48%
94.41
+26.70%
74.52
Net Income From Continuing And Discontinued Operation
128.49
+6.76%
120.36
+27.48%
94.41
+26.70%
74.52
Net Income Continuous Operations
128.49
+6.76%
120.36
+27.48%
94.41
+26.70%
74.52
Normalized Income
129.23
+7.06%
120.71
+23.96%
97.38
+12.32%
86.69
Net Income Common Stockholders
128.49
+6.76%
120.36
+27.48%
94.41
+26.70%
74.52
Diluted EPS
2.13
+4.93%
2.03
+25.31%
1.62
+25.58%
1.29
Basic EPS
2.17
+4.83%
2.07
+26.22%
1.64
+25.19%
1.31
Basic Average Shares
59.16
+1.61%
58.22
+1.09%
57.59
+1.39%
56.81
Diluted Average Shares
60.46
+1.84%
59.37
+1.73%
58.36
+1.19%
57.67
Diluted NI Availto Com Stockholders
128.49
+6.76%
120.36
+27.48%
94.41
+26.70%
74.52
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
2,685.92
+11.05%
2,418.60
+4.02%
2,325.24
+39.74%
1,663.97
Current Assets
1,040.15
+12.60%
923.77
-16.66%
1,108.47
+109.51%
529.08
Cash Cash Equivalents And Short Term Investments
446.40
+18.50%
376.71
-35.83%
587.04
+905.06%
58.41
Cash And Cash Equivalents
446.40
+18.50%
376.71
-35.83%
587.04
+905.06%
58.41
Receivables
223.61
+6.91%
209.17
+10.52%
189.26
+6.06%
178.45
Accounts Receivable
203.71
+7.08%
190.24
+6.95%
177.88
+8.02%
164.68
Gross Accounts Receivable
213.85
+6.94%
199.97
+6.99%
186.91
+7.98%
173.10
Allowance For Doubtful Accounts Receivable
-10.14
-4.18%
-9.73
-7.82%
-9.02
-7.12%
-8.42
Other Receivables
17.77
+7.14%
16.59
+57.73%
10.52
-19.05%
12.99
Taxes Receivable
2.13
-8.87%
2.33
+171.83%
0.86
+10.27%
0.78
Inventory
333.70
+9.03%
306.06
+0.72%
303.87
+14.24%
265.99
Raw Materials
110.70
+0.17%
110.51
-7.57%
119.56
+33.72%
89.41
Work In Process
32.39
+19.46%
27.11
+6.66%
25.42
-13.93%
29.53
Finished Goods
190.62
+13.17%
168.44
+6.01%
158.89
+8.05%
147.05
Prepaid Assets
4.94
+50.37%
3.29
-18.18%
4.02
+2.63%
3.91
Other Current Assets
31.49
+10.33%
28.54
+17.53%
24.29
+8.79%
22.32
Total Non Current Assets
1,645.77
+10.10%
1,494.83
+22.85%
1,216.77
+7.22%
1,134.88
Net PPE
516.00
+14.24%
451.67
+1.14%
446.57
-0.37%
448.24
Gross PPE
892.45
+11.10%
803.28
+3.57%
775.61
+3.21%
751.51
Accumulated Depreciation
-376.44
-7.06%
-351.61
-6.86%
-329.04
-8.50%
-303.27
Properties
0.00
0.00
0.00
0.00
Land And Improvements
30.46
+17.87%
25.85
-0.66%
26.02
+0.30%
25.94
Buildings And Improvements
200.05
+4.03%
192.30
+0.42%
191.49
+1.24%
189.15
Machinery Furniture Equipment
60.88
-0.71%
61.32
-2.73%
63.04
+3.13%
61.13
Construction In Progress
82.94
+41.36%
58.67
-4.50%
61.44
+0.28%
61.27
Other Properties
452.88
+11.44%
406.37
+6.95%
379.98
+4.29%
364.35
Leases
65.24
+11.00%
58.77
+9.57%
53.64
+7.98%
49.67
Goodwill And Other Intangible Assets
1,044.49
+8.60%
961.78
+35.82%
708.12
+11.39%
635.69
Goodwill
506.84
+9.35%
463.51
+21.26%
382.24
+6.23%
359.82
Other Intangible Assets
537.65
+7.91%
498.26
+52.90%
325.88
+18.13%
275.87
Investments And Advances
28.74
+25.89%
22.83
+19.78%
19.06
+22.37%
15.58
Other Investments
28.74
+25.89%
22.83
+19.78%
19.06
+22.37%
15.58
Non Current Deferred Assets
29.86
-18.76%
36.76
+43.61%
25.60
+14.45%
22.37
Non Current Deferred Taxes Assets
7.05
-56.06%
16.04
+120.14%
7.29
+10.44%
6.60
Other Non Current Assets
10.42
-15.75%
12.37
-12.81%
14.18
+33.64%
10.61
Total Liabilities Net Minority Interest
1,101.62
+6.00%
1,039.24
-7.48%
1,123.24
+116.19%
519.57
Current Liabilities
239.76
+10.80%
216.40
+6.31%
203.56
-7.74%
220.65
Payables And Accrued Expenses
228.64
+11.04%
205.91
+7.70%
191.19
-3.55%
198.22
Payables
81.68
-2.50%
83.77
+2.12%
82.03
-4.75%
86.13
Accounts Payable
60.55
-11.61%
68.50
+3.88%
65.94
-3.74%
68.50
Other Payable
12.28
+4.22%
11.78
+7.02%
11.01
+0.73%
10.93
Current Accrued Expenses
146.96
+20.32%
122.14
+11.89%
109.16
-2.62%
112.10
Total Tax Payable
8.85
+153.47%
3.49
-31.34%
5.09
-24.06%
6.70
Income Tax Payable
8.85
+153.47%
3.49
-31.34%
5.09
-24.06%
6.70
Current Debt And Capital Lease Obligation
10.88
+5.28%
10.33
-14.53%
12.09
-45.69%
22.25
Current Debt
—
—
—
11.25
Other Current Borrowings
—
—
—
11.25
Current Capital Lease Obligation
10.88
+5.28%
10.33
-14.53%
12.09
+9.83%
11.01
Current Deferred Liabilities
0.25
+56.33%
0.16
-44.56%
0.28
+72.73%
0.17
Total Non Current Liabilities Net Minority Interest
861.86
+4.74%
822.84
-10.53%
919.68
+207.66%
298.92
Long Term Debt And Capital Lease Obligation
810.70
+3.36%
784.33
-10.80%
879.27
+256.71%
246.50
Long Term Debt
734.04
+0.62%
729.55
-11.36%
823.01
+340.68%
186.76
Long Term Capital Lease Obligation
76.66
+39.93%
54.78
-2.62%
56.26
-5.82%
59.74
Tradeand Other Payables Non Current
17.54
-8.62%
19.20
+9.61%
17.51
+12.19%
15.61
Non Current Deferred Liabilities
21.06
+1109.13%
1.74
-75.64%
7.15
-64.54%
20.17
Non Current Deferred Revenue
1.40
-6.92%
1.50
-6.42%
1.60
-6.03%
1.71
Non Current Deferred Taxes Liabilities
19.66
+8093.75%
0.24
-95.67%
5.55
-69.95%
18.46
Other Non Current Liabilities
12.55
-28.54%
17.57
+11.61%
15.74
-5.44%
16.65
Stockholders Equity
1,584.30
+14.86%
1,379.36
+14.76%
1,202.00
+5.03%
1,144.40
Common Stock Equity
1,584.30
+14.86%
1,379.36
+14.76%
1,202.00
+5.03%
1,144.40
Capital Stock
763.91
+8.63%
703.22
+10.20%
638.15
-5.48%
675.17
Common Stock
763.91
+8.63%
703.22
+10.20%
638.15
-5.48%
675.17
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
59.42
+1.16%
58.74
+1.53%
57.86
+0.96%
57.31
Ordinary Shares Number
59.42
+1.16%
58.74
+1.53%
57.86
+0.96%
57.31
Retained Earnings
824.03
+18.47%
695.54
+20.92%
575.18
+19.64%
480.77
Gains Losses Not Affecting Retained Earnings
-3.64
+81.26%
-19.40
-71.18%
-11.33
+1.87%
-11.55
Other Equity Adjustments
-3.64
+81.26%
-19.40
-71.18%
-11.33
+1.87%
-11.55
Total Equity Gross Minority Interest
1,584.30
+14.86%
1,379.36
+14.76%
1,202.00
+5.03%
1,144.40
Total Capitalization
2,318.34
+9.93%
2,108.91
+4.14%
2,025.01
+52.12%
1,331.16
Working Capital
800.39
+13.15%
707.37
-21.83%
904.91
+193.38%
308.44
Invested Capital
2,318.34
+9.93%
2,108.91
+4.14%
2,025.01
+50.85%
1,342.41
Total Debt
821.57
+3.39%
794.66
-10.85%
891.36
+231.67%
268.75
Net Debt
287.63
-18.48%
352.84
+49.52%
235.98
+69.04%
139.60
Capital Lease Obligations
87.53
+34.43%
65.11
-4.73%
68.35
-3.39%
70.74
Net Tangible Assets
539.81
+29.27%
417.58
-15.45%
493.88
-2.91%
508.70
Tangible Book Value
539.81
+29.27%
417.58
-15.45%
493.88
-2.91%
508.70
Interest Payable
9.34
-1.96%
9.53
+512.53%
1.56
—
Non Current Note Receivables
16.25
+72.47%
9.42
+190.74%
3.24
+35.21%
2.40
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
297.37
+34.68%
220.80
+52.12%
145.15
+27.00%
114.29
Cash Flow From Continuing Operating Activities
297.37
+34.68%
220.80
+52.12%
145.15
+27.00%
114.29
Net Income From Continuing Operations
128.49
+6.76%
120.36
+27.48%
94.41
+26.70%
74.52
Depreciation Amortization Depletion
134.65
+17.36%
114.73
+13.27%
101.29
+9.86%
92.20
Depreciation
134.65
+17.36%
114.73
+13.27%
101.29
+9.86%
92.20
Depreciation And Amortization
134.65
+17.36%
114.73
+13.27%
101.29
+9.86%
92.20
Other Non Cash Items
6.54
-8.05%
7.11
+46.07%
4.87
-58.68%
11.78
Stock Based Compensation
43.46
+52.64%
28.47
+33.47%
21.33
+18.24%
18.04
Asset Impairment Charge
0.31
-31.36%
0.46
-9.88%
0.51
-77.82%
2.28
Deferred Tax
5.21
+135.06%
-14.87
-17.64%
-12.64
+15.28%
-14.92
Deferred Income Tax
5.21
+135.06%
-14.87
-17.64%
-12.64
+15.28%
-14.92
Operating Gains Losses
2.05
+37.79%
1.49
-72.44%
5.41
+200.89%
1.80
Gain Loss On Sale Of PPE
2.30
+54.50%
1.49
-74.48%
5.84
+1436.32%
0.38
Change In Working Capital
-23.34
+36.81%
-36.95
+47.24%
-70.02
+1.93%
-71.40
Change In Receivables
-2.73
+87.44%
-21.70
-127.39%
-9.54
-5.94%
-9.01
Changes In Account Receivables
-7.34
+46.36%
-13.69
-14.85%
-11.92
+21.17%
-15.12
Change In Inventory
-21.60
-844.56%
-2.29
+92.88%
-32.10
+33.02%
-47.93
Change In Prepaid Assets
-4.13
-15.23%
-3.59
-401.60%
1.19
+154.62%
-2.18
Change In Payables And Accrued Expense
20.50
+265.08%
5.62
+148.98%
-11.47
-1527.90%
0.80
Change In Accrued Expense
14.26
+46.80%
9.71
+491.10%
-2.48
+84.83%
-16.38
Change In Payable
6.24
+252.26%
-4.10
+54.36%
-8.98
-152.28%
17.18
Change In Account Payable
1.01
+143.69%
-2.31
+68.29%
-7.30
-157.63%
12.66
Change In Other Working Capital
-1.66
-181.53%
2.03
+6.67%
1.90
+166.82%
-2.85
Change In Other Current Assets
-1.70
+72.02%
-6.07
-1.51%
-5.98
-1009.59%
0.66
Change In Other Current Liabilities
-12.03
-9.92%
-10.95
+21.92%
-14.02
-28.71%
-10.89
Investing Cash Flow
-247.39
+32.89%
-368.65
-110.24%
-175.35
-205.50%
-57.40
Cash Flow From Continuing Investing Activities
-247.39
+32.89%
-368.65
-110.24%
-175.35
-205.50%
-57.40
Net PPE Purchase And Sale
—
0.01
-97.51%
0.20
+209.23%
0.07
Sale Of PPE
—
0.01
-97.51%
0.20
+209.23%
0.07
Capital Expenditure
-84.84
-123.00%
-38.04
-3.66%
-36.70
+23.86%
-48.20
Capital Expenditure Reported
-84.84
-123.00%
-38.04
-3.66%
-36.70
+23.86%
-48.20
Net Business Purchase And Sale
-144.77
+54.79%
-320.18
-138.01%
-134.52
-1614.54%
-7.85
Purchase Of Business
-144.77
+54.79%
-320.18
-138.01%
-134.52
-1614.54%
-7.85
Gain Loss On Sale Of Business
-0.25
0.00
+100.00%
-0.43
-130.42%
1.42
Net Other Investing Changes
-17.78
-70.51%
-10.43
-152.92%
-4.12
-192.00%
-1.41
Financing Cash Flow
16.00
+126.66%
-60.01
-110.73%
559.27
+1028.09%
-60.26
Cash Flow From Continuing Financing Activities
16.00
+126.66%
-60.01
-110.73%
559.27
+1028.09%
-60.26
Net Issuance Payments Of Debt
0.00
+100.00%
-99.06
-115.99%
619.58
+1478.74%
-44.94
Issuance Of Debt
0.00
0.00
-100.00%
1,199.20
+457.24%
215.21
Repayment Of Debt
0.00
+100.00%
-99.06
+82.91%
-579.62
-122.81%
-260.14
Long Term Debt Issuance
0.00
0.00
-100.00%
1,199.20
+457.24%
215.21
Long Term Debt Payments
0.00
+100.00%
-99.06
+82.91%
-579.62
-122.81%
-260.14
Net Long Term Debt Issuance
0.00
+100.00%
-99.06
-115.99%
619.58
+1478.74%
-44.94
Net Common Stock Issuance
28.21
-31.03%
40.91
+162.50%
15.58
-22.35%
20.07
Net Other Financing Charges
-12.21
-559.15%
-1.85
+97.56%
-75.90
-114.45%
-35.39
Changes In Cash
65.98
+131.74%
-207.86
-139.29%
529.07
+15818.06%
-3.37
Effect Of Exchange Rate Changes
3.80
+251.01%
-2.52
-419.63%
-0.48
+87.35%
-3.83
Beginning Cash Position
378.77
-35.71%
589.14
+872.86%
60.56
-10.62%
67.75
End Cash Position
448.55
+18.42%
378.77
-35.71%
589.14
+872.86%
60.56
Free Cash Flow
212.53
+16.29%
182.76
+68.52%
108.45
+64.10%
66.09
Interest Paid Supplemental Data
20.99
-9.69%
23.24
+65.43%
14.05
+124.53%
6.26
Income Tax Paid Supplemental Data
31.39
-30.31%
45.05
+42.85%
31.53
+84.50%
17.09
Change In Income Tax Payable
5.23
+393.00%
-1.78
-5.93%
-1.69
-137.27%
4.52
Change In Tax Payable
5.23
+393.00%
-1.78
-5.93%
-1.69
-137.27%
4.52
Common Stock Issuance
28.21
-31.03%
40.91
+162.50%
15.58
-22.35%
20.07
Issuance Of Capital Stock
28.21
-31.03%
40.91
+162.50%
15.58
-22.35%
20.07
Sale Of Business
—
0.00
-100.00%
0.43
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category